Literature DB >> 12007282

Imaging of aortic atherosclerotic lesions by (125)I-LDL, (125)I-oxidized-LDL, (125)I-HDL and (125)I-BSA.

A Shaish1, G Keren, P Chouraqui, H Levkovitz, D Harats.   

Abstract

OBJECTIVE: The aim of the present study was to compare the accumulation of (125)I-labeled low-density lipoproteins (LDL), oxidized LDL (oxLDL), HDL and BSA in advanced atherosclerotic lesions of apoE-deficient mice.
METHODS: (125)I-lipoproteins or (125)I-BSA were injected into the tail vein of apoE-deficient mice. Blood clearance of (125)I-lipoproteins and (125)I-BSA and their accumulation in atherosclerotic lesions were assayed.
RESULTS: Blood clearance of (125)I-LDL and (125)I-HDL was moderate, and approximately 30% of the injected lipoproteins were present in plasma 24 h following injection. oxLDL was removed much faster from plasma, and less than 10% of (125)I-oxLDL was present in the circulation 30 min after (125)I-oxLDL injection. The clearance of (125)I-BSA from the circulation was slower than the lipoprotein clearance. The highest accumulation of LDL, oxLDL, HDL and BSA was detected in atherosclerotic lesions in the aortic arch and abdominal aorta, while lower accumulation was detected in the less atherosclerotic descending thoracic aorta.
CONCLUSION: Our findings demonstrate that both (125)I-HDL and (125)I-BSA as well as (125)I-LDL are accumulated in atherosclerotic plaques and that they can be used for the detection of atherosclerotic lesions. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12007282     DOI: 10.1159/000055947

Source DB:  PubMed          Journal:  Pathobiology        ISSN: 1015-2008            Impact factor:   4.342


  13 in total

1.  Gold nanocrystal labeling allows low-density lipoprotein imaging from the subcellular to macroscopic level.

Authors:  Iris E Allijn; Wei Leong; Jun Tang; Anita Gianella; Aneta J Mieszawska; Francois Fay; Ge Ma; Stewart Russell; Catherine B Callo; Ronald E Gordon; Emine Korkmaz; Jan Andries Post; Yiming Zhao; Hans C Gerritsen; Axel Thran; Roland Proksa; Heiner Daerr; Gert Storm; Valentin Fuster; Edward A Fisher; Zahi A Fayad; Willem J M Mulder; David P Cormode
Journal:  ACS Nano       Date:  2013-10-17       Impact factor: 15.881

2.  HDL as a contrast agent for medical imaging.

Authors:  David P Cormode; Juan C Frias; Yanqing Ma; Wei Chen; Torjus Skajaa; Karen Briley-Saebo; Alessandra Barazza; Kevin Jon Williams; Willem Jm Mulder; Zahi A Fayad; Edward A Fisher
Journal:  Clin Lipidol       Date:  2009-08

Review 3.  Nanoparticles for Cardiovascular Imaging and Therapeutic Delivery, Part 2: Radiolabeled Probes.

Authors:  John C Stendahl; Albert J Sinusas
Journal:  J Nucl Med       Date:  2015-08-20       Impact factor: 10.057

4.  In Vivo PET Imaging of HDL in Multiple Atherosclerosis Models.

Authors:  Carlos Pérez-Medina; Tina Binderup; Mark E Lobatto; Jun Tang; Claudia Calcagno; Luuk Giesen; Chang Ho Wessel; Julia Witjes; Seigo Ishino; Samantha Baxter; Yiming Zhao; Sarayu Ramachandran; Mootaz Eldib; Brenda L Sánchez-Gaytán; Philip M Robson; Jason Bini; Juan F Granada; Kenneth M Fish; Erik S G Stroes; Raphaël Duivenvoorden; Sotirios Tsimikas; Jason S Lewis; Thomas Reiner; Valentín Fuster; Andreas Kjær; Edward A Fisher; Zahi A Fayad; Willem J M Mulder
Journal:  JACC Cardiovasc Imaging       Date:  2016-05-25

Review 5.  Modified natural nanoparticles as contrast agents for medical imaging.

Authors:  David P Cormode; Peter A Jarzyna; Willem J M Mulder; Zahi A Fayad
Journal:  Adv Drug Deliv Rev       Date:  2009-11-06       Impact factor: 15.470

Review 6.  Lipoproteins and lipoprotein mimetics for imaging and drug delivery.

Authors:  C Shad Thaxton; Jonathan S Rink; Pratap C Naha; David P Cormode
Journal:  Adv Drug Deliv Rev       Date:  2016-04-29       Impact factor: 15.470

7.  Nanocrystal Core Lipoprotein Biomimetics for Imaging of Lipoproteins and Associated Diseases.

Authors:  Francois Fay; Brenda L Sanchez-Gaytan; David P Cormode; Torjus Skajaa; Edward A Fisher; Zahi A Fayad; Willem J M Mulder
Journal:  Curr Cardiovasc Imaging Rep       Date:  2013-02-01

Review 8.  Molecular imaging of atherosclerosis.

Authors:  Mark P S Dunphy; H William Strauss
Journal:  Curr Cardiol Rep       Date:  2008-03       Impact factor: 2.931

Review 9.  High-density lipoprotein-based contrast agents for multimodal imaging of atherosclerosis.

Authors:  Torjus Skajaa; David P Cormode; Erling Falk; Willem J M Mulder; Edward A Fisher; Zahi A Fayad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-08       Impact factor: 8.311

10.  RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe.

Authors:  Wei Chen; Peter A Jarzyna; Geralda A F van Tilborg; Van Anh Nguyen; David P Cormode; Ahmed Klink; Arjan W Griffioen; Gwendalyn J Randolph; Edward A Fisher; Willem J M Mulder; Zahi A Fayad
Journal:  FASEB J       Date:  2010-01-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.